Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc.

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

Discover top medications for 'treating Parkinsons Disease'? This page compiles essential information on generic and brand-name drugs specifically used for Parkinsons Disease treatment.Here ...

WEHI researchers have solved a decades-long mystery by determining the structure of human PINK1, a key protein linked to ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

They treated flies with the drug IU1 ... advances in anti-aging therapy. "Reduced protein homeostasis is a major characteristic of degenerative diseases such as Alzheimer's and Parkinson's disease.

Pioneering Cancer TreatmentAnti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form ...

("Annovis"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), will ...